Outlook Therapeutics, Inc. · NASDAQ:OTLK
Empery Asset Management, LP reported a 7.57% stake in Outlook Therapeutics, Inc. (Schedule 13G)
Event Jun 30, 2025 · Filed Jul 31, 2025
Empery Asset Management, LP reported a 7.57% stake in Outlook Therapeutics, Inc., 3,195,641 shares, as a passive investor on Jun 30, 2025. Filed Jul 31, 2025 (Schedule 13G).
- Stake
- 7.57%
- Shares
- 3,195,641
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Empery Asset Management, LP | 7.57% | 3,195,641 |
| Ryan M. Lane | 7.57% | 3,195,641 |
| Martin D. Hoe | 7.57% | 3,195,641 |
Source
Related
- Outlook Therapeutics, Inc.
- Empery Asset Management, LP
- Outlook Therapeutics, Inc. shareholders
- Schedule 13G · Empery Asset Management, LP · Oct 13, 2026
- Schedule 13G/A · Empery Asset Management, LP · Oct 21, 2025
- Schedule 13G · CVI Investments, Inc. · Aug 19, 2026
- Form 4 · Jahr Robert Charles · Aug 14, 2026
- Form 4 · Kenyon Lawrence A · Aug 14, 2026
- Form 4 · Sukhtian Ghiath M. · Aug 14, 2026
- Schedule 13D/A · GMS Ventures & Investments · Aug 14, 2026